Companies: 10,795·Total market cap: $144.5T
Spruce Biosciences, Inc.

Spruce Biosciences, Inc.

SPRBNASDAQHealthcare● Active
$49.32
$-1.11(-2.20%)
Market Cap$67668470
P/E Ratio
52W High$838.125
52W Low$7
Overview

Spruce Biosciences, Inc. (SPRB) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SPRB · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-37.60sprb eps ttm · sprb earnings per shareEarnings history
PE Ratio (TTM)sprb pe ratio ttm · sprb price to earningsPE Ratio deep dive
Revenue (TTM)0.00sprb revenue ttm · sprb annual revenueFull revenue history
Dividend YieldNo Dividenddoes sprb pay dividends · sprb dividend yieldDividend history
Shares Outstanding766,598sprb shares outstanding · sprb floatShares outstanding history
Next EarningsAug 13, 2026Est.sprb earnings date · sprb next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00▼ 100.00% YoY
202320242025
spruce biosciences, inc. revenue · sprb revenue 2025
FY 2025Net Income-$39.0M▲ +26.53% YoY
202320242025
spruce biosciences, inc. net income · sprb profit 2025
FY 2025EPS$-50.83▲ +47.46% YoY
202320242025
sprb eps · spruce biosciences, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$37.2MEPS: $-37.60View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis sprb a buy · sprb analyst rating
Strong Buy
0
Buy
6
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$140.00Low
$49.32Current
$191.00Avg Target287.27% upside
$283.00High
sprb price target · sprb 12 month forecast

Total: 11 · Buy rate: 54.5%

The SPRB analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $191.00, representing +287.27% upside from the current price of $49.32.

Stock Performance

Full History
1D-2.20%
1W+2.56%
1M-12.71%
3M-11.72%
YTD-43.38%
1Y+996.00%
5Y-94.87%

About Spruce Biosciences, Inc.

CEOJavier Szwarcberg
IPO DateOct 9, 2020
Employees20
CountryUS

Spruce Biosciences, Inc. founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatmen…

what is spruce biosciences, inc. · sprb stock overview · spruce biosciences, inc. company profile · who is spruce biosciences, inc. ceo · sprb NASDAQ · spruce biosciences, inc. headquarters · spruce biosciences, inc. business segments

About Stock Overview & Key Data

Spruce Biosciences, Inc. (SPRB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 9, 2020. As of the latest trading session, SPRB stock price is $49.32, with a market capitalization of $67.7M. The stock has returned +996.00% over the past 12 months and -43.38% year-to-date.

According to 11 Wall Street analysts, the consensus rating for Spruce Biosciences, Inc. stock is Buy, with an average 12-month price target of $191.00. In fiscal year 2025, Spruce Biosciences, Inc. reported revenue of — and net income of -$39.0M. For detailed data — including Spruce Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Spruce Biosciences, Inc. (SPRB) stock price is $49.32. The stock is traded on NASDAQ under the ticker symbol SPRB. The 52-week range is $7.00 – $838.13.

SPRB stock priceSPRB quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice